Age-adjusted D-dimer cutoffs can safely rule out deep vein thrombosis (DVT) in many suspected cases, according to the ...
A targeted computerized alert at the time of physician order entry reduced the use of D-dimer testing among patients 65 years and older. A single-crossover cluster randomized trial of computerized ...
Measurement of plasma D-dimer levels – a test more commonly used to detect blood-clotting disorders – can provide useful information when making the difficult diagnosis of periprosthetic joint ...
New research suggests that it may be possible to simplify the diagnosis of deep vein thrombosis (DVT) without compromising accuracy. Contrary to the standard practice of administering several tests to ...
Tampa, FL (Oct. 26, 2021) --A screening blood test originally validated in seriously ill patients without COVID-19 is still clinically useful for ruling out pulmonary embolism in patients hospitalized ...
Use of clinical decision rules in conjunction with D-dimer thresholds adjusted higher based on either age or pretest probability is acceptably safe for ruling out acute pulmonary embolism (PE) without ...
Recognizing that D-dimer levels generally increase with advancing age, however, the age-adjusted D-dimer test is ...
The LumiraDx NT-proBNP and the LumiraDx D-Dimer tests are currently the only quantitative direct fingerstick assays produced for each test. Run on the highly portable LumiraDx Platform, they are ...
The ongoing coronavirus disease 2019 (COVID-19) pandemic, which has been caused by the rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has significantly affected the ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The plasma D-dimer assay has been used, along with clinical prediction scores, to rule out ...
The growing prevalence of thrombotic disorders and the rising focus on personalized medicine & precision healthcare are projected to drive the global D-dimer testing market's growth during the ...
Does an elevated ultrasensitive D-dimer level in a patient whose pre-test probability puts him at low risk for pulmonary embolus (PE) indicate an increased risk for PE or deep venous thrombosis (DVT)?